Category: Vaccines

Posted on

Ontario Teachers Pension Plan, And The Interesting Stocks They Own

https://twitter.com/ETFOeducators/status/1371865858046365704

The Elementary Teachers Federation of Ontario (ETFO) has publicly called for forcing masks on children, even those in kindergarten. However, not everything is as it appears. For example, the OTPP, the Ontario Teachers Pension Plan, owns $83 million in stock in 3M. This is a company that makes masks.

Also, an honourbale mention and shoutout to Stormhaven, who has covered this, and taken a different approach. Check that piece out as well, as it has lots of good information.

What else is in the OTPP (which includes both elementary and high school teachers)? Information on the holdings can be obtained for free at the U.S. SEC, the Securities and Exchanges Commission.

COMPANY AMOUNT
3M CO $83,000,000
Abbott Labs $355,000
Biogen Inc. $41,915,000
Eli Lilly & Co $1,110,000
Gilead Sciences $1,406,000
Globeus Med Inc. $513,000
Jazz Pharmaceuticals PLC $317,000
Johnson & Johnson $84,386,000
Medpace Holdings Inc. $393,000
Merck & Co. $406,000
Mersana Therapeutics $504,000
Moderna Inc. $970,000
Pfizer $599,000
Procter & Gamble $837,000
Regeneron Pharmaceuticals $736,000
Sarpeta Therapeutics $753,000
TEVA Pharmaceuticals $17,487,000
United Therapeutics Corp. $1,077,000
Vertex Pharmaceuticals $502,000
West Pharmaceutical SVSC $797,000

$83 million in 3M, a company that manufactures facemasks. This is one of those things that makes you go “hmmm….”, doesn’t it?

In addition to owning parts of companies involved in health care and pharmaceuticals, the OTPP has other interests in businesses that will also profit from extended lockdowns, and the “Great Reset”. Here are some of them:

COMPANY AMOUNT
Amazon Group $287,000
Apple $1,104,000
Bank of America Corp $579,000
Black Hills Corp $322,000
Blackstone Group $413,000
Costco Wholesale $943,000
Goldman Sachs $1,714,000
Home Dept $81,854
Kroger Co. $662,000
McDonald’s Corp. $81,651,000
Microsoft $244,167,000
PayPal Holdings $542,000
Pepsico $853,000
Rogers Communications $743,000
Shaw Communications $906,000
Tesla Inc. $561,455,000
Tri Pointe Group Inc. $1,118,000
Twitter Inc. $257,000
Verizon Communications $860,000
Visa Inc. $83,780,000
Zoom Video Communications $392,000

It’s not much of a stretch to see that the OTPP stands to benefit from lockdowns and the “Great Reset”. After all, they are heavily invested in industries and companies that will profit from the current situation.

In addition to owning part of 3M, this Pension Plan also owns considerable stock in Gilead Sciences, Eli Lilly, Merck, Moderna, Pfizer, Teva, and over $84 million in Johnson & Johnson. This could explain their support for the vaccine agenda. Then again, it could all just be a coincidence.

It could also be a coincidence that Jo Taylor, who’s in charge of the OTPP, has ties to the World Economic Forum. Likewise, it may just be happenstance that Mark Wiseman, who runs Blackrock (which owns SNC Lavalin), used to run the CPPIB, and helped set up the OTPP.

Read into it what you will.

(1) https://www.sec.gov/edgar/browse/?CIK=937567
(2) https://archive.is/EFPhz
(3) Submissions At End Of December 2020
(4) https://archive.is/PQnkQ
(5) SEC Filings, Total Pension Fund Assets, December 2020
(6) https://archive.is/SKUga
(7) https://www.weforum.org/agenda/authors/jo-taylor
(8) https://www.weforum.org/people/mark-wiseman

(9) Ontario Teachers, World Economic Forum
(10) Healthcare Of Ontario Pension Plan’s Holdings

Posted on

CV #66(G): Patty Hajdu Lies: Rigorous Testing WASN’T Required To Get “Vaccines” Onto Market

Canadians are constantly told that these gene therapy “vaccines” are safe, and have undergone strict testing in order to be allowed on the market. But what exactly are those standards? And is it normal practice to include a clause making authorization mandatory?

People should know that if the product injures or kills them, indemnification agreements prevent the manufacturers from getting sued. A vaccine injury compensation program was announced back in December, but appears to have gone nowhere.

As a reminder, Interim Authorization and Approval are quite different, and cannot be used interchangeably.

(a) Approved: Health Canada has fully reviewed all the testing, and steps have been done, with the final determination that it can be used for the general population
(b) Interim Authorization: deemed to be “worth the risk” under the circumstances, doesn’t have to be fully tested. Allowed under Section 30.1 of the Canada Food & Drug Act. Commonly referred to as an emergency use authorization.

If you read the inserts provided by Health Canada (see below), they will all claim to be “authorized under Section 5 of an Interim Order”. Fine, but what is that Order, and what does it actually say?

Issuance
5 The Minister must issue an authorization in respect of a COVID-19 drug if the following requirements are met:

(a) the applicant has submitted an application to the Minister that meets the requirements set out in subsection 3‍(1) or 4‍(2);
(b) the applicant has provided the Minister with all information or material, including samples, requested under subsection 13‍(1) in the time, form and manner specified under subsection 13‍(2); and
(c) the Minister has sufficient evidence to support the conclusion that the benefits associated with the drug outweigh the risks, having regard to the uncertainties relating to the benefits and risks and the necessity of addressing the urgent public health need related to COVID-19.

Several of these “vaccines”, and I use the term loosely, were given Interim Authorization under Section 5 of an Interim Order signed by Health Minister Patty Hajdu on September 16, 2020. The above criteria is all that is required.

Note: Section 5 starts out with “The Minister must” issue and authorization. It’s not that “The Minister should”, or “The Minister may” issue one, but the Minister MUST.

Also, the above requirements are not very strict. 3(1) or 4(2) must be met, along with 13(1) and 13(2). And all that’s needed is the very subjective standard that the “Minister has sufficient evidence to support the conclusion”. It doesn’t specify what, if any, standard there is. The Minister only needs to see is as “worth the risk” given the uncertainties there are.

It’s worth noting that Health Canada doesn’t do the testing themselves. Instead, they rely heavily on the documentation provided. Quite the trust system.

Application for authorization
3 (1) Subject to section 4, an application for an authorization in respect of a COVID-19 drug must be in a form established by the Minister and contain sufficient information and material to enable the Minister to determine whether to issue the authorization, including
.
(a) the applicant’s name and contact information and, in the case of a foreign applicant, the name and contact information of their representative in Canada;
(b) a description of the drug and a statement of its proper name or its common name if there is no proper name;
(c) a statement of the brand name of the drug or the identifying name or code proposed for the drug;
a list of the ingredients of the drug, stated quantitatively;
(d) the specifications for each of the drug’s ingredients;
(e) a description of the facilities and equipment to be used in the manufacture, preparation and packaging of the drug;
(f) details of the method of manufacture and the controls to be used in the manufacture, preparation and packaging of the drug;
(g) details of the tests to be applied to control the potency, purity, stability and safety of the drug;
(h) the names and qualifications of all the investigators to whom the drug has been sold;
(i) a draft of every label to be used in connection with the drug, including any package insert and any document that (j) is provided on request and that sets out supplementary information on the use of the drug;
(k) a statement of all the representations to be made for the promotion of the drug respecting
(i) the recommended route of administration of the drug,
(ii) the proposed dosage of the drug,
(iii) the drug’s indications, and
(iv) the contra-indications and side effects of the drug;
(l) a description of the dosage form that is proposed for the sale of the drug;
(m) evidence that all test batches of the drug used in any studies conducted in connection with the application were manufactured and controlled in a manner that is representative of market production;
(n) in the case of a drug intended for administration to food-producing animals, the withdrawal period of the drug; and
(o) the known information in relation to the quality, safety and effectiveness of the drug.

About part (n), it says “administration to food-producing animals”. Are we to assume that livestock are going to be vaccinated with these substances at some point? Or are we repurposing drugs that were originally meant for them? That’s a bit unsettling.

Application for authorization – foreign drug
4 (1) An application for an authorization in respect of a COVID-19 drug may be based on a comparison to a foreign drug if the sale of the foreign drug is authorized by a foreign regulatory authority on the basis of information submitted to the authority in relation to the quality, safety and effectiveness of that drug.
.
Content
(2) The application must be in a form established by the Minister and contain the following information and material:
.
(a) the information and material described in paragraphs 3‍(1)‍(a) to (d), (f), (j) to (l) and, if applicable, (n);
(b) an attestation, signed and dated by an individual who has authority to bind the applicant in Canada, certifying that the applicant has access to the information referred to in paragraph 3‍(1)‍(o) that was submitted to the relevant foreign regulatory authority in order for the foreign drug to be authorized to be sold;
(c) information that demonstrates that the drug is identical to, and is manufactured, prepared and packaged in the same manner as, the foreign drug;
(d) information that demonstrates that the sale of the foreign drug is authorized by the foreign regulatory authority referred to in paragraph (b); and
(e) any labels that are approved by the foreign regulatory authority referred to in paragraph (b) for use in connection with the foreign drug.

Request for information or material
13 (1) The Minister may request that a person that has submitted an application for an authorization in respect of a COVID-19 drug or the holder of such an authorization provide any information or material, including samples, that is necessary to enable the Minister to determine whether to issue, amend or suspend the authorization.
.
Time, form and manner
(2) The person or holder, as the case may be, must provide the information, material or samples in the time, form and manner specified by the Minister.

Section 3(1) lists what documentation needs to be submitted to get authorization. Section 4(2) contains a few extra steps for foreign drugs. Sections 13(1) and (2) state that information and samples must be provided if demanded.

The standard for Interim Authorization under Section 5 appears to be a fairly low one. Keep in mind, the Minister doesn’t even need to be certain the drugs work as advertised. It just has to be determined to be worth the risk. Not quite what we are told on the news.

As for the basis in the law, Section 30.1 of the Canada Food & Drug Act allows the Health Minister to sign such Orders, if it’s believed, (or claimed to be believed), it’s in the public interest. There is no requirement that the Minister have any appropriate education background, or know what he/she is talking about.

Circling back to the top of Section 5, the Health Minister “must issue an authorization” if the conditions in Section 5 are met?!?! So this isn’t discretionary? Our graphic designer Minister must sign off on this?

It’s also unsettling that this Order allows for drugs originally intended for livestock to be repurposed and tested on humans.

WHO Paper On MANDATORY Vaccination April 13, 2021 (Original)
WHO Paper On MANDATORY Vaccination April 13, 2021 (Copy)
Section 30.1 Canada Food & Drug Act
September 2020 Interim Order From Patty Hajdu
https://www.canada.ca/en/public-health/news/2020/12/government-of-canada-announces-pan-canadian-vaccine-injury-support-program.html
https://covid-vaccine.canada.ca/info/pdf/astrazeneca-covid-19-vaccine-pm-en.pdf
https://covid-vaccine.canada.ca/info/pdf/janssen-covid-19-vaccine-pm-en.pdf
https://covid-vaccine.canada.ca/info/pdf/covid-19-vaccine-moderna-pm-en.pdf
https://covid-vaccine.canada.ca/info/pdf/pfizer-biontech-covid-19-vaccine-pm1-en.pdf

Testing Product Insert AstraZeneca Interim Authorization
Testing Product Insert Janssen Interim Authorization
Testing Product Insert Moderna Interim Authorization
Testing Product Insert Pfizer Interim Authorization

Vaccines Supported For Pregnant Women, Despite No Testing
Vaccines Given “Interim Authorization”, Not Approval. Very Different
Call Centers Wrongly Telling People “Vaccines” Are Approved
Ontario Adds, Then Removes Protections Against “No Jab, No Job”
WHO April 13 Paper: Discussion On Mandatory “Experimental Vaxx”

Posted on

Another Toronto Court Challenge, But Will This One Actually Go Anywhere?

There was an online announcement of a Notice of Application filed in the Toronto Branch of Ontario Superior Court, Civil Division. Predictably, it caused a buzz in the alternative media. Several commented that it was disappointing the mainstream outlets chose not to cover it.

While that is a valid point, there is another one to raise: how come other complaints have dropped off of people’s radars? There was one filed in October 2019 that is collecting dust 18 months later. There is also a high profile suit filed July 2020 with no defenses submitted almost a year later. True, there was a temporary moratorium on filing deadlines, but that lapsed September 14, 2020. There doesn’t appear to have been any attempt to either force that case ahead, or seek default judgement.

The average person may not know this, but it’s quite easy to search for a case in Ontario and see what progress, if any, has been made. If Parties aren’t even represented, that can also be found out.

Despite there being no movement in those cases, a defamation lawsuit was filed in December 2020. Interesting how actual human rights violations are worth only $11 million, but mean words on Twitter is worth $12.75 million. Perhaps there is some deeper insight that isn’t obvious.

Now, what people choose to do in their private lives is their business. That being said, when asking for donations from the public to finance a lawsuit, it’s worthwhile to ensure the money is going where it’s supposed to be.

One example last year was Action4Canada/Liberty Talk raising money for the promise of a lawsuit in B.C., against Bonnie Henry. Now, the fundraising started in September 2020 (if not earlier), so that has been 8 months now. The promised lawsuit has not materialized. Odessa Orlewicz has spoken about pocketing 25% of it.

It sounds great (on the surface) that another challenge was launched. However, it must be asked: will anything become of it? Or will it fade away, like its predecessors?

On the topic of covering court cases: it’s worth pointing out that various Libel & Slander Acts provide a number of defenses for people reporting on them. These include truth, opinion, public interest, and acting in good faith. Also, there are anti-SLAPP laws (strategic lawsuits against public participation), that ensure reporters and journalists will have a wide breadth to cover important events. For anyone wanting to publish information on court cases, this is important to know.

Posted on

Healthcare Of Ontario Pension Plan (HOOPP) Owns Stock In Vaccines & Masks Being Pushed

The Ontario Science Table lists groups in the health care sector as its partners. Whether or not the individual members support this, and to what extent, the pensions of a lot of people are tied up in promoting their agenda.

HOOPP, the Healthcare of Ontario Pension Plan has some interesting medical holdings. This is at least according the SEC, or U.S. Securities and Exchanges Commission. While there is nothing inherently bad in investing in your own field, it will be driven by the way you want it to go.

The fund claims to have over $100 billion in net assets, or equity. Fair enough, let’s take a look at where some of that money is.

COMPANY AMOUNT
1Life Healthcare $540,000
3M Co. $462,000
Alexion Pharmaceuticals $34,891,000
Alnylam Pharmaceuticals $213,000
Alpha Healthcare Acquisition Corp $2,232,000
Amplitude Health Care Acquisition $930,000
Bausch Health Cos $2,366,000
Biogen Inc. $235,000
CVS Health Corp $32,871
Cytomx Therapeutics Inc. $835,000
Deerfield Healthcare Technology Acquisition $2,696,000
DFP Healthcare Acquisition $3,633,000
Gilead Sciences $6,420,000
HCA Healthcare $142,000
Healthcare Merger Corp. $1,019,000
Jazz Pharmaceuticals PLC $3,538,000
Johnson & Johnson $34,401,000
Livongo Health Inc. $6,169,000
Merck & Co. $6,221,000
Pfizer $38,467,000
Regeneron Pharmaceuticals $1,052,000

The individual companies weren’t named in the HOOPP paperwork, so a visit to the SEC was needed for that. For reference, Gilead is the manufacturer of Veklury, also known as Remdesivir, a drug (not a vaccine) to counter Covid-19. It was given interim authorization to be used in Canada. Janssen (which is owned by Johnson & Johnson) also has an authorized “vaccine” in Canada. So does Pfizer, which is partnered with BioNTech. Yes, these are the same companies.

As for the next group, this is on the list of things that will make you go “hmmm”. If health care workers in Ontario were expecting, or wanting, a shutdown of society, these would be the companies to invest in.

A serious question: does it come across as a conflict of interest when health care workers are pushing pharmaceuticals which their pension plans own stock in? And it gets stranger.

COMPANY AMOUNT
Alibaba Group Holdings $730,000,000
Alphabet Inc. $4,799,000
Amazon $18,848
Beyond Meat Inc. $151,000
Blackline Software $16,000
Blackrock $85,000
Blackstone Group $625,000
Broadcom Inc. $181,000
Coca Cola Co. $58,552,000
Dish Network Corporation $89,000
E-Bay $101,000
Facebook $24,022,000
Goldman Sachs $15,978,000
Grid Dynamics Inc. $4,676,000
Mastercard $427,644,000
Microsoft Corp. $298,081
Netflix $335,000
Nike $2,354
PayPal Holdings $378,000
Salesforce $2,746,000
Shaw Communications $6,386,000
Shopify $50,537,000
Starbucks $11,065,000
Visa $1,802,000
Walmart $13,148,000
Zoom Communications $216,000

HOOPP seems to be investing in everything that we need in order to have a cashless society, working from home, and an abundance of pharmaceuticals. But that’s probably just a coincidence.

While most of the profiles of the HOOPP leadership were privatized, a few were in the open. Some interesting details revealed in them.

Tanya Pereira is the Senior Director of Operations at HOOPP. She is also a Strategic Advisor at Andone Pharmaceuticals, during that same time period.

John Watson is the Director of Operations Support at HOOPP. He has also been charge of other pension plans. Early in his career, he was a records supervisor at Sick Kids Hospital Toronto, which gets significant funding from the Gates Foundation.

HOOPP claims to be pushing the ESG/green agenda pretty hard. So expect that they’ll only be investing in such companies that “appear” to be green, regardless of whether or not they actually are green. They sing the praises about sustainability and climate change. Most people have heard it all before.

As for the HOOPP owning stock in these vaccines and masks, and their members pushing them on the public, that is downright shady, to say the least. True, it’s the doctors and nurses themselves who market it to the lay person, but how does this look?

Is this ancient? According to the SEC, it covers the period up to December 31, 2020, and was filed on March 1, 2021. Now, it’s possible that these shares have since been sold, but the first interim authorizations were coming out before then. Again, how does it look?

IMPORTANT LINKS
(1) https://hoopp.com/
(2) https://hoopp.com/about-hoopp
(3) https://hoopp.com/investments/pension-plan-performance-and-hoopp-annual-report
(4) https://hoopp.com/about-hoopp/pension-leadership
(5) https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/authorization/list-drugs.html
(6) https://covid-vaccine.canada.ca/veklury/product-details
(7) https://covid-vaccine.canada.ca/janssen-covid-19-vaccine/product-details
https://www.sec.gov/Archives/edgar/data/1535845/000153584520000007/0001535845-20-000007-index.htm
https://www.sec.gov/Archives/edgar/data/1535845/000153584520000007/xslForm13F_X01/SEC13F09_2020.xml
https://archive.is/Kqazd

EARLIER IN THIS SERIES
(a) Michael Warner Financially Benefits From Prolonged Lockdowns
(b) Who Is Ontario Deputy Medical Officer, Barbara Yaffe?
(c) OST, Monopoly From The University Of Toronto Connected
(d) OST, University Of Toronto, Look At Their Members And Partners
(e) OST’s Robert Steiner Claims To Be Behind PHAC Canada Creation
(f) OST’s Kwame McKenzie Headed 2017 UBI Pilot Project
(g) OST UofT Prelude Actually Set Out In May 2019
(h) OST’s Murty Has Tech Firm That Benefits From Lockdowns
(i) OST: Como Foundation Gives Trillium Health Partners $5M
(j) OST: Current PHO Officials Also Sitting On As Partners
(k) OST: Canadian Agency For Drugs & Technologies In Health; pCPA
(l) OST: Centre For Effective Practice Gets Money From Lockdown
(m) OST: Cochrane Canada; WHO; McMaster University
(n) OST: SPOR Evidence Alliance Gets Funding From WHO

Posted on

OST; WHO; Canadian Agency for Drugs and Technologies in Health (CADTH), Pan-Canadian Pharmaceutical Alliance

The Canadian Agency for Drugs and Technologies in Health (CADTH), is a partner of the Ontario Science Table, or OST. However, CADTH is also a working group for the World Health Organization, Health Evidence Network. Now, OST “claims” to be a neutral and independent body giving scientific and medical advice. Question, is CADTH compromised, or can this do really serve 2 (or more) masters?

The Health Evidence Network describes itself in the following way:

Recognizing that public health, health care and health systems policy-makers need access to timely, independent and reliable health information for decision-making, WHO/Europe started HEN in 2003. It acts as a platform, providing evidence in multiple formats to help decision-making.

The Health Evidence Network also claims to be independent, much the way OST does. Interestingly, they always have the exact same recommendations to make.

Previously Theresa Tam got flack for being on a World Health Organization Committee, while simultaneously claiming to represent Canada as the Public Health Officer. It seems these kinds of conflicts of interest are normal, and not the exception.

CADTH, the Canadian Agency for Drugs and Technologies in Health, claims to be

an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

Created in 1989 by Canada’s federal, provincial, and territorial governments, CADTH was born from the idea that Canada needs a coordinated approach to assessing health technologies. The result was an organization that harnesses Canadian expertise from every region and produces evidence-informed solutions that benefit patients in jurisdictions across the country.

CADTH claims to be independent, just like OST claims to be independent. The WHO Health Evidence Network also says that it’s an independent entity. Keep that in mind, as it will become important later on. Now, who actually runs CADTH?

  • David Agnew: held the position of President and CEO of UNICEF Canada, and was the first head of the organization recruited from outside the international development sector. He is the past Chair of Sunnybrook Health Sciences Centre and of Colleges Ontario. He also serves on numerous other boards and committees, including the Toronto Region Immigrant Employment Council, the Council on Foreign Relations’ Higher Education Working Group on Global Issues, the Sichuan University International Advisory Board, the CivicAction Steering Committee and the Canadian Ditchley Foundation Advisory Board. He is a former member of the federal government’s Science, Technology, and Innovation Council, a former director of ventureLAB and the Empire Club of Canada, and has served on the campaign cabinets of the United Way in Toronto and Peel.
  • Marcel Saulnier, Associate Assistant Deputy Minister, Strategic Policy Branch, Health Canada
  • Western Provinces, Mitch Moneo, Assistant Deputy Minister, Pharmaceutical Services Division, Ministry of Health, British Columbia
  • Mark Wyatt, Assistant Deputy Minister, Saskatchewan Ministry of Health
  • Territories, Stephen Samis, Deputy Minister, Health and Social Services, Government of Yukon
  • Ontario, Patrick Dicerni, Assistant Deputy Minister, Drugs and Devices Division and Executive Officer, Ontario Public Drug Programs
  • Atlantic Provinces, Jeannine Lagassé, Associate Deputy Minister of Health and Wellness, Province of Nova Scotia.
  • Karen Stone, Deputy Minister of Health and Community Services (NL)
  • Health Systems, Dr. Brendan Carr, President and CEO of the Nova Scotia Health Authority

The Board of Directors of CADTH primarily is made up of high level bureaucrats in Canada, such as Associate Deputy Ministers. Far from being independent, this board is in fact connected to Provincial and Federal Governments.

  • drugs
  • diagnostic tests
  • medical, dental, and surgical devices and procedures

CADTH makes recommendations whether to accept certain medical devices and procedures. They also make recommendations on pharmaceuticals. This is interesting, considering that they don’t seem to do any research themselves. In fact, looking up the term “gene therapy” nets a lot of results.

Strange, because aren’t the Pfizer and Moderna mRNA “vaccines” really just a form of gene replacement therapy? It seems this technology has been around for a while.

Although this may seem harmless enough, there is another aspect to what these Provincial bureaucrats are doing. It’s not only that they want to review and make recommendations, but they want to PROMOTE cheap pharmaceuticals as well.

The pan-Canadian Pharmaceutical Alliance (pCPA) is an alliance of the provincial, territorial and federal governments that collaborates on a range of public drug plan initiatives to increase and manage access to clinically effective and affordable drug treatments.

One of pCPA’s key roles is to conduct joint negotiations for brand name and generic drugs in Canada in order to achieve greater value for publicly funded drug programs and patients through its combined negotiating power. Its objectives are to:

  • increase access to clinically effective and cost-effective drug treatment options;
  • achieve consistent and lower drug costs for participating jurisdictions;
  • reduce duplication of effort and improve use of resources; and
  • improve consistency of decisions among participating jurisdictions.

    • (Alberta) Chad Mitchell, Assistant Deputy Minister
    (British Columbia) Mitch Moneo, Assistant Deputy Minister (Vice-Chair, Acting)
    (Manitoba) Teresa Mrozek, (A) Assistant Deputy Minister
    (New Brunswick) Mark Wies, Assistant Deputy Minister
    (Newfoundland & Labrador) John McGrath, (A) Assistant Deputy Minister
    (Northwest Territories) Derek Elkin, Assistant Deputy Minister
    (Nova Scotia) Natalie Borden, Executive Director
    (Nunavut) Donna Mulvey, Territorial Director
    (Ontario) Patrick Dicerni, Assistant Deputy Minister; Executive Officer
    (Prince Edward Island) Lori Ellis, Director of Health Workforce Planning and Pharmacy
    (Quebec) Lucie Opatrny, Assistant Deputy Minister
    (Saskatchewan) Mark Wyatt, Assistant Deputy Minister (Chair)
    (Yukon) Amy Riske, Assistant Deputy Minister
    (Federal) Scott Doidge, Director General

    Notice anything? Just like with CADTH, the pan-Canadian Pharmaceutical Alliance is also run by top bureaucrats in the Governments. In fact, Mitch Moneo of B.C., and Mark Wyatt of Saskatchewan sit on both groups. the goal of this group is getting cheap, generic drugs available to all Canadians.

    Now, these bureaucrats, and their colleagues, are also involved with the Canadian Agency for Drugs and Technologies in Health, which approves drugs, procedures, and medical devices.

    And CADTH is a partner of the Ontario Science Table, which is pushing: mass vaccination, drugs for other health issues, mandatory masks, and lockdowns which will drive up the use of internet and virtual health care.

    The pCPA site explains the process like this:
    Health Canada reviews the drugs, which is not the same as actually testing them. Then CADTH and INESSS (the Quebec counterpart), review it to see if this is a cost effective way to go. Then pCPA tries to negotiate for cheaper and more affordable drug prices. Eventually it gets worked into public and private drug plans.

    Back to the original point: the Ontario Science Table claims to be an independent group. But it’s partnered with (among others) CADTH, who plays a major role in advancing big pharma in Canada.

    IMPORTANT LINKS
    (a) https://www.euro.who.int/en/data-and-evidence/evidence-informed-policy-making/health-evidence-network-hen/technical-members/current-technical-members/canadian-agency-for-drugs-and-technologies-in-health-cadth,-canada
    (b) https://covid19-sciencetable.ca/our-partners/
    (c) https://www.cadth.ca/about-cadth
    (d) https://www.cadth.ca/about-cadth/who-we-are/board-of-directors
    (e) https://www.pcpacanada.ca/
    (f) https://www.pcpacanada.ca/governance
    (g) https://www.pcpacanada.ca/faq
    (h) https://www.pcpacanada.ca/about

    EARLIER IN THIS SERIES
    (a) Michael Warner Financially Benefits From Prolonged Lockdowns
    (b) Who Is Ontario Deputy Medical Officer, Barbara Yaffe?
    (c) OST, Monopoly From The University Of Toronto Connected
    (d) OST, University Of Toronto, Look At Their Members And Partners
    (e) OST’s Robert Steiner Claims To Be Behind PHAC Canada Creation
    (f) OST’s Kwame McKenzie Headed 2017 UBI Pilot Project
    (g) OST UofT Prelude Actually Set Out In May 2019
    (h) OST’s Murty Has Tech Firm That Benefits From Lockdowns
    (i) Como Foundation Gives Trillium Health Partners $5M
    (j) Current PHO Officials Also Sitting On Ontario Science Table

    Posted on

    Public Health Ontario A Semi-Autonomous Corporation, Whose Leaders Sit With ON Science Table

    According to the Ontario Agency for Health Protection and Promotion Act, 2007, the Ontario Agency for Health Protection and Promotion was created, which is now referred to as Public Health Ontario. The timing is interesting, given that its creation aligns with the 2005 Quarantine Act, which itself is the result of the 3rd Edition of the International Health Regulations from the World Health Organization.

    For some background information, here is more on the WHO-IHR, the Quarantine Act, and Ontario‘s own Health Act. It’s worth also addressing PHAC, and its self-proclaimed advisor, Robert Steiner, who also sits on OST. These are not independent events, but are directly linked.

    This entity (referred to as Public Health Ontario, or PHO), is set up and structured as a corporation. It’s a Crown Corporation, mostly autonomous from the Government.

    Powers
    7 (1) Except as limited by this Act, the Corporation has the capacity, rights and powers of a natural person for carrying out its objects. 2007, c. 10, Sched. K, s. 7 (1).

    This group is to have the same rights and powers as an actual person which is not weird at all. The Act also indemnifies any employees or officers or directors from any liability, as long as they claim to be acting in good faith.

    IMMUNITY AND UNPAID JUDGMENTS
    No actions or proceedings against Crown
    26 No proceeding for damages or otherwise shall be commenced against the Crown, the Minister or any person employed by the Crown with respect to any act done or omitted to be done or any decision of the Corporation, a director or officer of the Corporation, a member of a standing committee or a person employed by the Corporation. 2007, c. 10, Sched. K, s. 26.

    Immunity from civil action
    27 (1) No proceeding for damages or otherwise shall be commenced against the Minister, a director or officer of the Corporation, a member of a standing committee, or any person employed by the Crown or the Corporation, with respect to any act done or omitted to be done or any decision under this Act that is done in good faith in the execution or intended execution of a power or duty under this Act. 2007, c. 10, Sched. K, s. 27 (1); 2011, c. 1, Sched. 6, s. 7 (1).

    Nothing shows that people take responsibility for their actions quite like giving them a pass for the possible consequences. There are limited provisions for taking action against the Crown itself, but not members involved.

    Anyhow, that Act specifies that this corporation is to act as an autonomous and mostly independent group from the Government. This would be similar to Alberta Health Services operates.

    Now, PHO is structured as a corporation, and is designed to be an arm’s length operation from the Crown. Okay. But looking at who runs it, some familiar faces appear.

    • Brian Schwartz is Vice President of PHO
    • Vanessa Allen is Chief, Microbiology and Laboratory Science at PHO
    • Jessica Hopkins, Chief Health Protection and Emergency Preparedness Officer at PHO
    • Samir Patel, Deputy Chief, Microbiology and Laboratory Science at PHO

    Some interesting names in the Leadership of Public Health Ontario. Why should we care about who any of them are? There’s a really simple reason.

    In case it wasn’t clear, here is the point: several high ranking members of Public Health Ontario are also members of the Ontario Science Table. Keep in mind, the OST presents itself as neutral and independent expert advice. At the same time, officials from a Crown Corporation in that same Province are part of their organization.

    Considering that PHO functions as an extension of the World Health Organization, and implements their dictates, what kind of perspectives will these people bring to OST? Will they simply implement the same ideas, cloaked as “science”, or will they offer radically different policies? So far, it seems to be the former.

    When these people speak at OST events and gatherings, are they talking as scientists working independently for the health of Ontarians overall? Or, are they acting in the capacity of Public Health Ontario representatives? Unless the OST is an extension of PHO, there are bound to be conflicts of interest.

    It’s a bit like Theresa Tam, who has a page as the Public Health Officer of Canada, but who also as a page for a World Health Organization Advisory Committee. These people even use the same photographs.

    On a related note: Deputy Prime Minister, and Finance Minister, Chrystia Freeland is also a Trustee at the World Economic Forum. Other prominent politicians are also involved with that organization.

    The mess that is the covered before, and more is likely to be added. Far from being independent, OST is rotten to the core with conflicts of interests, and members who have side ventures.

    Do the OST and Trillium Health Partners really think that mask mandates are in the public’s best interest? Or did a $5 million donation from a mask manufacturer change their minds? Does Michael Warner‘s side business influence his support for lockdowns? What About Kumar Murty‘s business interests? Or Kwame McKenzie‘s 2017 Ontario UBI project?

    Final thoughts to readers in Ontario: do you have any clue who is really running health care in Ontario? Do you know who is actually running the Province? Who’s behind the martial law masked as medical necessity? Think Doug Ford or Christine Elliott are anything but puppets?

    *Disclaimers, Ethics* Proudly powered by WordPress